ScienceDaily (Feb. 23, 2010) — Glioblastoma is one of the most deadly human brain cancers. Radiation can temporarily shrink a tumor, but they nearly always recur within weeks or months and few patients survive longer than two years after diagnosis.
Now scientists at the Stanford University School of Medicine studying the tumor in mice have found a way to stop the cancer cells from growing back after radiation by blocking its access to oxygen and nutrients. The discovery happened when...
Pittsburgh Neurosurgeons Explore Use of Drug that Illuminates Brain Tumor Cells To Guide Surgery
PITTSBURGH, Feb. 18 /PRNewswire-USNewswire/ -- Neurosurgeons at Allegheny General Hospital (AGH) are exploring use of a drug that illuminates brain tumor cells to determine if the experimental visualization technique will enhance their ability to surgically excise tumors and improve patient survival.
AGH is one of just three medical centers in the country approved by...
CANCER RESEARCH UK and Cancer Research Technology - the charity's development and commercialisation arm - have reached a collaboration agreement with immatics Biotechnologies to trial their new treatment vaccine, IMA950, for glioblastoma multiforme (GMB), one of the most common forms of brain cancer*.
IMA950 is the fifth treatment to enter Cancer Research UK's Clinical...
ScienceDaily (Feb. 12, 2010) — Scientists from the U.S. Department of Energy's Argonne National Laboratory and the University of Chicago Medical Center are shaking up the world of materials science and cancer research on the cover of the February 2010 issue of the journal Nature Materials.
Brain cancer is notoriously difficult to treat with standard cancer-fighting methods, so scientists have been looking outside standard medicine and into nanomaterials as a treatment alternative....
ScienceDaily (Feb. 10, 2010) — Researchers at Washington University School of Medicine in St. Louis have shown once again that "ready, fire, aim," nonsensical though it may sound, can be an essential approach to research.
The scientists robotically "fired" 2,000 compounds into culture plates containing tumor cells to see if the compounds had any effect. When the robotic screener found one substance had scored a hit by inhibiting growth of the tumor cells in its plate,...
Blog Categories
Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
(2)
